U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. CDER Offices and Divisions
  6. Biomedical Informatics and Regulatory Review Science (BIRRS)
  1. CDER Offices and Divisions

Biomedical Informatics and Regulatory Review Science (BIRRS)

BIRRS is a multidisciplinary team of clinical and data experts that develops novel tools and approaches to regulatory review activities across OND, as well as standardizes review approaches. The team supports OND-wide initiatives that bridge clinical expertise, informatics, and best practices for analyses and interpretation of diverse data. The BIRRS team leverages subject matter expertise along with analytic and machine learning methodologies to advance their work. The team also collaborates with external stakeholders (e.g., PHUSE, ICH) to harmonize clinical trial reporting and analyses.

Our work includes:

  • Standard Safety Tables & Figures (ST&F): Data displays that reflect best practices gleaned from medical journals, subject matter experts, and data standard publications.
  • FDA Medical Queries (FMQ): Standard groupings of adverse event terms designed by FDA to help identify potential safety issues during review of clinical trial adverse event data.
  • Data Standards: Therapeutic-area technical specifications pertaining to sponsor submitted data sets that improve data consistency and reviewability.

Contact Us

E-mail: ONDBiomedicalinformatics@fda.hhs.gov

Resources

 



Back to Top